Telomerase Reverse Transcriptase Promoter Mutations in Bladder Cancer: High Frequency Across Stages, Detection in Urine, and Lack of Association with OutcomeYves Allory, Francisco X. Real, Willemien Beukers et al.|European Urology|2013Cited by 289
Molecular Grade (FGFR3/MIB-1) and EORTC Risk Scores Are Predictive in Primary Non–Muscle-Invasive Bladder CancerBas W.G. van Rhijn, Theodorus van der Kwast, Tahlita C.M. Zuiverloon et al.|European Urology|2010Cited by 193
Markers Predicting Response to Bacillus Calmette-Guérin Immunotherapy in High-Risk Bladder Cancer Patients: A Systematic ReviewTahlita C.M. Zuiverloon, Ellen C. Zwarthoff, Annemieke J.M. Nieuweboer et al.|European Urology|2011Cited by 175
<i>Fibroblast Growth Factor Receptor 3</i> Mutation Analysis on Voided Urine for Surveillance of Patients with Low-Grade Non-Muscle–Invasive Bladder CancerTahlita C.M. Zuiverloon, Ellen C. Zwarthoff, Madelon N.M. van der Aa et al.|Clinical Cancer Research|2010Cited by 102
A SNaPshot assay for the rapid and simple detection of four common hotspot codon mutations in the PIK3CA geneCarolyn D. Hurst, Margaret A. Knowles, Tahlita C.M. Zuiverloon et al.|BMC Research Notes|2009Cited by 98